US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals

Watchlist
  • 18.200
  • -0.330-1.78%
Close Jun 18 16:00 ET
  • 18.200
  • 0.0000.00%
Post 16:18 ET
1.29BMarket Cap140.00P/E (TTM)

About Kiniksa Pharmaceuticals Company

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA.

Company Profile

SymbolKNSA
Company NameKiniksa Pharmaceuticals
Listing DateMay 24, 2018
Issue Price18.00
Founded2015
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-431-9100
Websitehttp://www.kiniksa.com

Company Executives

  • Name
  • Position
  • Salary
  • Sanj K. Patel
  • Chief Executive Officer and Chairman of the Board
  • 5.30M
  • Ross Moat
  • Senior Vice President and Chief Commercial Officer
  • --
  • Mark Ragosa
  • Senior Vice President and Chief Financial Officer
  • --
  • John F. Paolini, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.79M
  • Eben Tessari
  • Senior Vice President and Chief Operating Officer
  • 1.75M
  • Michael R. Megna
  • Chief Accounting Officer and Group Vice President, Finance
  • --
  • Thomas R. Malley
  • Independent Director
  • 380.36K
  • Dr. Felix J. Baker,PhD
  • Lead Independent Director
  • 411.06K
  • Kimberly J. Popovits
  • Independent Director
  • 362.66K
  • Dr. Stephen R. Biggar,M.D.,PhD
  • Independent Director
  • 371.96K
  • Tracey L. McCain, Esq.
  • Independent Director
  • 365.36K
  • G. Bradley Cole
  • Independent Director
  • 365.36K
  • Dr. Barry D. Quart,Pharm.D.
  • Independent Director
  • 372.55K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 459.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg